Kraft Heinz said on Tuesday it would not launch products with artificial colours... Shares in the gene-editing starup Verve Therapeutics have soared more than 77 per... The total loan book of credit ...

Eli Lilly agreed to acquire Verve Therapeutics for approximately $1 billion up front, adding a potential treatment for ...

Lilly has struck multiple partnership deals with gene-editing companies in the last two years to expand its portfolio beyond ...

U.S. stock index futures declined amid the ongoing Israel-Iran conflict, affecting global markets. Investor focus remains on ...

Stock futures were falling Tuesday and oil prices rose as Israel and Iran continued to exchange missile attacks and President ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...